Table 3.
Estimations of deposited concentrations of PM1, TSP and LDSA in the in vivo, OMICS-ALI and Tox-ALI exposures
| Spruce | Pine | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| parameter | Unit | device | In vivo | OMICS-ALI | Tox-ALI | In vivo | OMICS-ALI | Tox-ALI | ||
| Normal deposition | Enhanced deposition | Normal deposition | Enhanced deposition | |||||||
| PM1 | ng cm−2 | ELPI | 18.6 ± 22.0 | 380 ± 462 | 1480 ± 1800 | 470 ± 95.3 | 32.1 ± 26.4 | 590 ± 500 | 2300 ± 1950 | 690 ± 360 |
| TSP | ng cm− 2 | TEOM | 25.9 ± 34 | 570 ± 701 | 2220 ± 2730 | 660 ± 180 | 50.0 ± 39.0 | 950 ± 790 | 3710 ± 3080 | 1100 ± 640 |
| LDSA | 1x106μm2cm− 3 | NSAM | 73.0 ± 78 | 1.6 ± 1.7 | 6.2± 6.6 | 1.84 ± 0.41 | 110 ± 81.0 | 1.91 ± 1.38 | 7.4 ± 5.4 | 2.23 ± 0.01 |
PM1 Particulate matter with aerodynamic diameter < 1 μm, TSP total suspended particles, LDSA lung deposited surface area.
The values shown are calculated as averages from three test cycles ± standard deviations